期刊
TRENDS IN PHARMACOLOGICAL SCIENCES
卷 23, 期 6, 页码 288-293出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/S0165-6147(02)02037-0
关键词
-
资金
- NIA NIH HHS [AG 09464] Funding Source: Medline
Age-related changes in hormone levels are determinants of a variety of human diseases. Insulin is known to affect numerous brain functions including cognition and memory, and several clinical studies have established links between Alzheimer's disease (AD), insulin resistance and diabetes mellitus. These are reinforced by biological studies that reveal the effects of insulin on the molecular and cellular mechanisms that underlie the pathology of AD. For example, insulin regulates phosphorylation of tau protein, which underlies neurofibrillary lesions in the brains of AD patients. Insulin also affects the metabolism of P-amyloid, the main constituent of AD amyloid pathology. Here, we discuss clinical and biological data that highlight potential targets for therapeutic intervention.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据